Cargando…
In silico prediction of drug therapy in catecholaminergic polymorphic ventricular tachycardia
KEY POINTS: The mechanism of therapeutic efficacy of flecainide for catecholaminergic polymorphic ventricular tachycardia (CPVT) is unclear. Model predictions suggest that Na(+) channel effects are insufficient to explain flecainide efficacy in CPVT. This study represents a first step toward predict...
Autores principales: | Yang, Pei‐Chi, Moreno, Jonathan D., Miyake, Christina Y., Vaughn‐Behrens, Steven B., Jeng, Mao‐Tsuen, Grandi, Eleonora, Wehrens, Xander H. T., Noskov, Sergei Y., Clancy, Colleen E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784170/ https://www.ncbi.nlm.nih.gov/pubmed/26515697 http://dx.doi.org/10.1113/JP271282 |
Ejemplares similares
-
The Antiarrhythmic Mechanisms of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia
por: Li, Yukun, et al.
Publicado: (2022) -
Efficacy of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia Is Mutation-Independent but Reduced by Calcium Overload
por: Hwang, Hyun Seok, et al.
Publicado: (2019) -
Molecular Changes in the Cardiac RyR2 With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
por: Dulhunty, Angela F.
Publicado: (2022) -
Catecholaminergic Polymorphic Ventricular Tachycardia
por: Abbas, Mohamed, et al.
Publicado: (2022) -
Alternans in Genetically Modified Langendorff-Perfused Murine Hearts Modeling Catecholaminergic Polymorphic Ventricular Tachycardia
por: Sabir, Ian N., et al.
Publicado: (2010)